Biography
Jeff Stanaway, PhD, MPH, is Assistant Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. He is part of the research team for the landmark Global Burden of Disease and Geospatial Analysis. In this role, he models morbidity and mortality from enteric diseases, rabies, dengue, trachoma, and the hepatitides. His research focuses on macro-epidemiology with a special interest in understanding connections between the physical environment (e.g., climate and land cover) and the spatiotemporal distribution of disease and how these connections may inform surveillance and research.
Dr. Stanaway received his PhD in Epidemiology from the University of Washington and his MPH from the University of Arizona. During his graduate work, Dr. Stanaway served as an Epi Scholars Intern with Public Health – Seattle & King County, where he conducted research on using viral load to predict the timing of antiretroviral therapy. In his doctoral research, he explored the landscape ecology of hand, foot, and mouth disease (HFMD) in China and the potential role of climate change as a driver in the emergence of HFMD in Asia. He also began developing and validating a novel method to detect unknown animal reservoirs based on a disease’s associations with land cover pattern.
IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.
GBD 2019 Indonesia Subnational Collaborators. The state of health in Indonesia’s provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Global Health. 11 October 2022. doi: 10.1016/S2214-109X(22)00371-0.
Stanaway JD, Afshin A, Ashbaugh C. Health effects associated with vegetable consumption: a Burden of Proof study. Nature Medicine. 10 October 2022. doi: 10.1038/s41591-022-01970-5.
Zheng P, Afshin A, Biryukov S, et al. The Burden of Proof studies: assessing the evidence of risk. Nature Medicine. 10 October 2022. doi: 10.1038/s41591-022-01973-2.
GBD 2019 Diabetes and Air Pollution Collaborators. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. The Lancet Planetary Health. 6 July 2022. doi:/10.1016/S2542-5196(22)00122-X.
Burkart KG, Brauer M, Aravkin AY, Godwin WW, Hay SI, He J, Iannucci VC, Larson SL, Lim SS, Liu J, Murray CJL, Zheng P, Zhou M, Stanaway JD. Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study. The Lancet. 19 August 2021. doi: 10.1016/S0140-6736(21)01700-1.
India State-Level Disease Burden Initiative Air Pollution Collaborators. The health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019. The Lancet Planetary Health. 21 December 2020. doi:10.1016/S2542-5196(20)30298-9.
GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 27 August 2020. doi:10.1016/S0140-6736(20)30750-9.
Brauer M, Zhao JT, Bennitt FB, Stanaway JD. Global Access to Handwashing: Implications for COVID-19 Control in Low-Income Countries. Environmental Health Perspectives. 15 May 2020. doi:10.1289/EHP7200.
GBD 2016 Occupational Risk Factors Collaborators. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. Occupational and Environmental Medicine. 13 February 2020. doi: 10.1136/oemed-2019-106008.
GBD 2016 Occupational Carcinogens Collaborators. Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016. Occupational and Environmental Medicine. 13 February 2020. doi:10.1136/oemed-2019-106012.
GBD 2016 Occupational Chronic Respiratory Risk Factors Collaborators. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. Occupational and Environmental Medicine. 13 February 2020. doi:10.1136/oemed-2019-106013.
GBD 2017 Lower Respiratory Infections Collaborators. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 30 October 2019. doi:10.1016/S1473-3099(19)30410-4.
GBD 2017 Diarrhoeal Disease Collaborators. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 30 October 2019. doi:10.1016/S1473-3099(19)30559-6.
GBD 2017 Non-Typhoidal Salmonella Invasive Disease Collaborators. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 24 September 2019. doi:10.1016/S1473-3099(19)30418-9.
GBD 2017 Typhoid and Paratyphoid Collaborators. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 18 Feb 2019. doi:10.1016/ S1473-3099(18)30685-6.
India State-Level Disease Burden Initiative Air Pollution Collaborators. The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. The Lancet Planetary Health. 5 Dec 2018. doi: https://doi.org/10.1016/S2542-5196(18)30261-4
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1859–922. doi: http://dx.doi.org/10.1016/S0140-6736(18)32335-3.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1923-94. doi: http://dx.doi.org/10.1016/S0140-6736(18)32225-6.
GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018; 392:2091–138. doi: http://dx.doi.org/10.1016/S0140-6736(18)32281-5.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1736-88. doi: http://dx.doi.org/10.1016/S0140-6736(18)32203-7.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1789–858. doi: http://dx.doi.org/10.1016/S0140-6736(18)32279-7.
GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 19 September 2018. doi:10.1016/S1473-3099(18)30407-9.
GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 19 September 2018. doi:10.1016/S1473-3099(18)30424-9.
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 23 May 2018.
India State-level Disease Burden Initiative Collaborators. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. The Lancet. 13 Nov 2017. doi: http://dx.doi.org/10.1016/S0140-6736(17)32804-0
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1151–210.
GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1260-344.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390; 1211–59.
GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 12 Sept 2017: 390; 1423–59.
GBD 2015 Eastern Mediterranean Region Collaborators. Danger ahead: the burden of diseases, injuries, and risk factors 3 in the Eastern Mediterranean Region, 1990–2015. International Journal of Public Health. 7 Aug 2017.
GBD 2015 Eastern Mediterranean Region Collaborators. Adolescent health in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. International Journal of Public Health. 7 Aug 2017.
GBD 2015 Eastern Mediterranean Region Collaborators. Neonatal, infant, and under-5 mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. International Journal of Public Health. 7 Aug 2017.
GBD 2015 Eastern Mediterranean Region Collaborators. Burden of vision loss in the Eastern Mediterranean region, 1990–2015: findings from the Global Burden of Disease 2015 study. International Journal of Public Health. 7 Aug 2017.
Deribew A, Dejene T, Kebede B, Tessema GA, Melaku YA, Misganaw A, Gebre T, Hailu A, Biadgilign S, Amerbir A, Yirsaw BD, Abajobir AA, Shafi O, Abera SF, Negussu N, Mengistu B, Tadesse Z, Sileshi M, Cromwell E, Glenn SD, Deribe K, Stanaway JD. Incidence, prevalence and mortality rates of malaria in Ethiopia from 1990 to 2015: analysis of the global burden of diseases 2015. Malaria Journal. 2017 Jul 4;16:271. doi: 10.1186/s12936-017-1919-4.
The Global Burden of Disease Child and Adolescent Health Collaboration. Child and adolescent health from 1990 to 2015: Findings from the Global Burden of Disease, Injuries, and Risk Factors 2015 Study. JAMA Pediatrics. 2017;171(6):1-21. doi:10.1001/jamapediatrics.2017.0250.
Kyu HH, Mumford JE, Stanaway JD, Barber RM, Hancock JR, Vos T, Murray CJL, Naghavi M. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017 Feb 8. doi: 10.1186/s12889-017-4111-4.
Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease study. JAMA Oncology. 2016 Dec 3. doi:10.1001/jamaoncol.2016.5688.
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1603–1658.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1459–1544.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1545–1602.
Lim SS, Allen K, Bhutta ZA, et al. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet. 2016 Sep 21. doi: 10.1016/S0140-6736(16)31467-2.
Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, Vos T. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. The Lancet Infectious Diseases. 2016 Sept 20.
Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. The Lancet Infectious Diseases. 2016 Apr 15. doi: 10.1016/S1473-3099(16)00146-8.
Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: an analysis from the Global Burden of Disease study 2013. The Lancet Infectious Diseases. 2016 Feb 10. doi: 10.1016/S1473-3099(16)00026-8.
Kyu HH, Pinho C, Wagner JA, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: Findings from the Global Burden of Disease 2013 study. JAMA Pediatrics. 2015 Jan 25. doi: 10.1001/jamapediatrics.2015.4276.
Newton JN, Briggs ADM, Murray CJL, et al. Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 Sep 15. doi: 10.1016/S0140-6736(15)00195-6.
Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015 Aug 27. doi: 10.1016/S0140-6736(15)61340-X.
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 June 8. doi: 10.1016/S0140-6736(15)60692-4.
Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 Dec 17. doi: 10.1016/S0140-6736(14)61682-2.
Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJL, Naghavi M. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine. 2014; 12:145.